刺五加苷 E结构式
|
常用名 | 刺五加苷 E | 英文名 | Eleutheroside E |
|---|---|---|---|---|
| CAS号 | 39432-56-9 | 分子量 | 742.718 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 935.7±65.0 °C at 760 mmHg | |
| 分子式 | C34H46O18 | 熔点 | 255 - 260ºC | |
| MSDS | 中文版 美版 | 闪点 | 519.7±34.3 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
刺五加苷 E用途刺五加苷E (Eleutheroside E)是刺五加的重要成分,具有抗炎,保护缺血心脏的作用。 |
| 中文名 | 刺五加甙 E |
|---|---|
| 英文名 | Eleutheroside E |
| 中文别名 | 刺五加甙E | 刺五加苷E,五加苷E | 刺五加苷E | 刺五加苷E | 五加苷E | 刺五加苷 E | 刺五加甙 |
| 英文别名 | 更多 |
| 描述 | 刺五加苷E (Eleutheroside E)是刺五加的重要成分,具有抗炎,保护缺血心脏的作用。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 935.7±65.0 °C at 760 mmHg |
| 熔点 | 255 - 260ºC |
| 分子式 | C34H46O18 |
| 分子量 | 742.718 |
| 闪点 | 519.7±34.3 °C |
| 精确质量 | 742.268433 |
| PSA | 254.14000 |
| LogP | -3.91 |
| InChIKey | FFDULTAFAQRACT-JSGUJALWSA-N |
| SMILES | COc1cc(C2OCC3C(c4cc(OC)c(OC5OC(CO)C(O)C(O)C5O)c(OC)c4)OCC23)cc(OC)c1OC1OC(CO)C(O)C(O)C1O |
| 外观性状 | 无色微结晶粉末 |
| 蒸汽压 | 0.0±0.3 mmHg at 25°C |
| 折射率 | 1.616 |
| 储存条件 | 2-8°C |
|
[Studies on chemical constituents from stem barks of Fraxinus paxiana].
Zhongguo Zhong Yao Za Zhi 33(16) , 1990-3, (2008) To investigate the chemical constituents of Fraxinus paxiana.The chemical constituents were isolated and purified by chromatographic techniques and the structures of the compounds were identified with... |
|
|
[Chemical constituents from flowers of Chrysanthemum indicum].
Zhongguo Zhong Yao Za Zhi 35(6) , 718-21, (2010) To investigate the chemical constituents of the flowers of Chrysanthemum indicum.The chemical constituents were isolated by various column chromatographic methods. The structures were identified by sp... |
|
|
[Studies on phenylpropanoids from herbs of Eriophyton wallichii].
Zhongguo Zhong Yao Za Zhi 33(22) , 2636-9, (2008) To study the chemical constituents of Eriophyton wallichii.Compounds were separated and purified by column chromatographic methods, and their structures were elucidated by spectroscopic methods.Eight ... |
| 4-{(1R,3aR,4S,6aS)-4-[4-(β-L-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl β-D-glucopyranoside |
| β-D-Glucopyranoside, 4-[(1R,3aR,4S,6aS)-4-[4-(β-L-glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenyl |
| β-D-Glucopyranoside, 4-[(1R,3aS,4S,6aR)-4-[4-(β-L-glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenyl |
| (2R,3S,4R,5R,6S)-2-[4-[6-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| 4-{(1R,3aS,4S,6aR)-4-[4-(β-L-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl β-D-glucopyranoside |